GGGSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRs
12.25USDD
+0.40+3.55%
Cập nhật lần cuối vào 20:00 GMT 12 thg 11
USD
Không có giao dịch
Trái phiếu
Sau đây là danh sách trái phiếu doanh nghiệp GSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRs. Các nhà đầu tư thường lựa chọn trái phiếu của công ty vì tính ổn định cao hơn trong thời điểm thị trường biến động. Nghiên cứu giá cả, lợi suất và các số liệu thống kê khác và tìm khoản đầu tư đáng tin cậy.
Mã | Lợi suất đáo hạn % | Khối lượng | Giá % | Phiếu giảm giá % | Ngày đáo hạn | Giá trị dư nợ | Giá trị khuôn mặt | Giá trị mệnh giá tối thiểu | Bên phát hành |
|---|---|---|---|---|---|---|---|---|---|
| 117RIGlaxoSmithKline Capital Plc 4.25% 18-DEC-2045 | 5.61% | 8.46 K | 82.51% | 4.250% | 2045-12-18 | 370.79 M GBP | 1,000.00 GBP | 100,000.00 GBP | GlaxoSmithKline Capital Plc |
| 883GIGlaxoSmithKline Capital Plc 5.25% 10-APR-2042 | 5.53% | 0 | 96.95% | 5.250% | 2042-04-10 | 477.82 M GBP | 1,000.00 GBP | 50,000.00 GBP | GlaxoSmithKline Capital Plc |
| 771ZCGlaxoSmithKline Capital Plc 6.375% 09-MAR-2039 | 5.38% | 0 | 109.25% | 6.375% | 2039-03-09 | 631.3 M GBP | 1,000.00 GBP | 50,000.00 GBP | GlaxoSmithKline Capital Plc |
| GGSK3981911GlaxoSmithKline Capital, Inc. 4.2% 18-MAR-2043 | 5.31% | 200 K | 87.49% | 4.200% | 2043-03-18 | 500 M USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital, Inc. |
| XXS217060907GlaxoSmithKline Capital Plc 1.625% 12-MAY-2035 | 5.18% | 0 | 73.85% | 1.625% | 2035-05-12 | 750 M GBP | 1,000.00 GBP | 100,000.00 GBP | GlaxoSmithKline Capital Plc |
| GGSK.GJGlaxoSmithKline Capital, Inc. 6.375% 15-MAY-2038 | 5.01% | 2.09 M | 112.54% | 6.375% | 2038-05-15 | 2.75 B USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital, Inc. |
| GGSK6023693GlaxoSmithKline Capital, Inc. 4.875% 15-APR-2035 | 4.72% | 750 K | 101.15% | 4.875% | 2035-04-15 | 750 M USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital, Inc. |
| 772WIGlaxoSmithKline Capital, Inc. 5.375% 15-APR-2034 | 4.67% | 0 | 105.28% | 5.375% | 2034-04-15 | 500 M USD | 1,000.00 USD | 1,000.00 USD | GlaxoSmithKline Capital, Inc. |
| AAG99GlaxoSmithKline Capital Plc 5.25% 19-DEC-2033 | 4.65% | 0 | 103.98% | 5.250% | 2033-12-19 | 574.17 M GBP | 1,000.00 GBP | 1,000.00 GBP | GlaxoSmithKline Capital Plc |
| GGSK6023695GlaxoSmithKline Capital, Inc. 4.5% 15-APR-2030 | 4.16% | 285 K | 101.35% | 4.500% | 2030-04-15 | 850 M USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital, Inc. |
| UUS377373AH8GlaxoSmithKline Capital Plc 3.375% 01-JUN-2029 | 4.13% | 0 | 97.54% | 3.375% | 2029-06-01 | 1 B USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital Plc |
| XXS217060184GlaxoSmithKline Capital Plc 1.25% 12-OCT-2028 | 4.08% | 0 | 92.37% | 1.250% | 2028-10-12 | 750 M GBP | 1,000.00 GBP | 100,000.00 GBP | GlaxoSmithKline Capital Plc |
| UUS377372AN7GlaxoSmithKline Capital, Inc. 3.875% 15-MAY-2028 | 4.08% | 0 | 99.55% | 3.875% | 2028-05-15 | 1.75 B USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital, Inc. |
| GGSK6023691GlaxoSmithKline Capital Plc 4.315% 12-MAR-2027 | 3.81% | 28 K | 100.65% | 4.315% | 2027-03-12 | 400 M USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital Plc |
| XXS293369275GSK Capital BV 3.25% 19-NOV-2036 | 3.54% | 0 | 97.33% | 3.250% | 2036-11-19 | 600 M EUR | 1,000.00 EUR | 100,000.00 EUR | GSK Capital BV |
| XXS255381776GSK Capital BV 3.125% 28-NOV-2032 | 3.27% | 0 | 99.11% | 3.125% | 2032-11-28 | 700 M EUR | 1,000.00 EUR | 100,000.00 EUR | GSK Capital BV |
| XXS293369143GSK Capital BV 2.875% 19-NOV-2031 | 3.09% | 0 | 98.83% | 2.875% | 2031-11-19 | 700 M EUR | 1,000.00 EUR | 100,000.00 EUR | GSK Capital BV |
| XXS182282979GlaxoSmithKline Capital Plc 1.75% 21-MAY-2030 | 2.86% | 0 | 95.33% | 1.750% | 2030-05-21 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | GlaxoSmithKline Capital Plc |
| XXS168152035GlaxoSmithKline Capital Plc 1.375% 12-SEP-2029 | 2.78% | 0 | 94.97% | 1.375% | 2029-09-12 | 500 M EUR | 1,000.00 EUR | 100,000.00 EUR | GlaxoSmithKline Capital Plc |
| XXS255381768GSK Capital BV 3.0% 28-NOV-2027 | 2.47% | 0 | 101.04% | 3.000% | 2027-11-28 | 500 M EUR | 1,000.00 EUR | 100,000.00 EUR | GSK Capital BV |
| XXS182282812GlaxoSmithKline Capital Plc 1.25% 21-MAY-2026 | 2.26% | 0 | 99.49% | 1.250% | 2026-05-21 | 1 B EUR | 1,000.00 EUR | 100,000.00 EUR | GlaxoSmithKline Capital Plc |
| GGX5BGlaxoSmithKline Capital Plc 1.0% 12-SEP-2026 | 2.25% | 0 | 98.99% | 1.000% | 2026-09-12 | 700 M EUR | 1,000.00 EUR | 100,000.00 EUR | GlaxoSmithKline Capital Plc |
| 117RNGlaxoSmithKline Capital Plc 3.375% 20-DEC-2027 | 0.87% | 0 | 112.19% | 3.375% | 2027-12-20 | 307.77 M GBP | 1,000.00 GBP | 100,000.00 GBP | GlaxoSmithKline Capital Plc |
| GGSK6023692GlaxoSmithKline Capital Plc FRN 12-MAR-2027 | — | 10.8 M | 100.39% | 4.701% | 2027-03-12 | 600 M USD | 1,000.00 USD | 2,000.00 USD | GlaxoSmithKline Capital Plc |
| AAQ72GlaxoSmithKline Capital Plc 0.883% 21-SEP-2028 | — | — | — | 0.883% | 2028-09-21 | 42.5 B JPY | 100,000,000.00 JPY | 100,000,000.00 JPY | GlaxoSmithKline Capital Plc |